Artesunate clinical trials
Also written Artesunic acid.
Counted the way a researcher would: Artesunate with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Artesunate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Artesunate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 May 2020 · ARTESUNATE · NDA 213036 (FDA, Drugs@FDA)
- European Union
- 22 Nov 2021 · Artesunate Amivas · EMEA/H/C/005550 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Brand
- Arsumax®
- 1
Studies by the year they started
114 studies that test it; most in 2005 (10)
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 4 |
| 2005 | 10 |
| 2006 | 9 |
| 2007 | 9 |
| 2008 | 7 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 3 |
| 2012 | 6 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 4 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 98
London School of Hygiene and Tropical Medicine (12) · Sanofi (6) · Centers for Disease Control and Prevention (5) · University of Oxford (5) · Armed Forces Research Institute of Medical Sciences, Thailand (5) · Frantz Viral Therapeutics, LLC (4) · Centre Muraz (4) · Medical University of Vienna (4)
Often tested with
Tested in the same studies.
Amodiaquine (32) · Fanasil, pyrimethamine drug combination (14) · Mefloquine (12) · Artemether, Lumefantrine Drug Combination (11) · Artenimol (5) · Piperaquine (5) · Chloroquine (5) · Artemether (3)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 6
Studies that test Artesunate.
- Dec 2026Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)Phase 2 · Frantz Viral Therapeutics, LLC
- Dec 2026Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSILPhase 2 · Frantz Viral Therapeutics, LLC
- Dec 2026Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative ParticipantsPhase 2 · Frantz Viral Therapeutics, LLC
- Feb 2027AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRPNot applicable · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Jun 2027Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination TherapyPhase 2 · Obafemi Awolowo University
- Jun 2027Safety and Efficacy of Oral Artesunate for Pre-cervical CancerPhase 2 · Metanoic Health Ltd.
Studies
Open first, then newest update. How each study uses Artesunate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 115
- AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRPNot yet recruitingNot applicableUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNCT07933757Written as Artesunate
- Study Evaluating the Efficacy and Safety of ArtesunateRecruitingPhase 2Amivas Inc.NCT06853184Written as Artesunate
- A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial HypertensionRecruitingPhase 1Joseph C. WuNCT06872112Written as Artesunate
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)RecruitingPhase 2Frantz Viral Therapeutics, LLCNCT04098744Written as Artesunate vaginal insert
- Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3)RecruitingPhase 2Frantz Viral Therapeutics, LLCNCT06075264Written as Artesunate ointment
- Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/ III Colorectal CancerNot yet recruitingPhase 2Metanoic Health Ltd.NCT07095309Written as Artesunate
- Safety and Efficacy of Oral Artesunate for Pre-cervical CancerNot yet recruitingPhase 2Metanoic Health Ltd.NCT07095478Written as Artesunate
- Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative ParticipantsRecruitingPhase 2Frantz Viral Therapeutics, LLCNCT06206564Written as Artesunate ointment
- Safety and Efficacy of Artesunate & Curcumin in Crohn's DiseaseRecruitingPhase 2Sanjay Gandhi Postgraduate Institute of Medical SciencesNCT04713631Written as Artesunate
- A Safety and Effectiveness Study of Pre-operative Artesunate in Stage II/III Colorectal CancerRecruitingPhase 2St George's, University of LondonNCT02633098Written as Artesunate 200mg
- Improving Treatment Outcomes in Chronic Myeloid Leukaemia Patients Using Imatinib and Artesunate Combination TherapyActive, not recruitingPhase 2Obafemi Awolowo UniversityNCT07022743Written as Artesunate
- Pharmacokinetic Study of IV Artesunate to Treat Children With Severe MalariaCompletedPhase 4National Institute of Allergy and Infectious Diseases (NIAID)NCT05750459Written as Artesunate
- Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)CompletedPhase 1/2Institut National de la Santé Et de la Recherche Médicale, FranceNCT04921930Written as Artesunate Oral Product
- Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in KenyaCompletedPhase 1UNC Lineberger Comprehensive Cancer CenterNCT06263582Written as Artesunate pessary
- Artesunate Pessaries (Vaginal Inserts) for Cervical Precancer in KenyaCompletedPhase 1UNC Lineberger Comprehensive Cancer CenterNCT06165614Written as Artesunate pessary
- Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19CompletedPhase 2Shin Poong Pharmaceutical Co. Ltd.NCT04532931Written as Artesunate-amodiaquine
- Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSILActive, not recruitingPhase 2Frantz Viral Therapeutics, LLCNCT05555862Written as Artesunate
- Parasite Clearance and Protection From Infection (PCPI) in ZambiaCompletedPhase 3London School of Hygiene and Tropical MedicineNCT06166498Written as AS (Guilin Pharmaceuticals)
- Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3)CompletedPhase 1Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT03792516Written as artesunate ointment 40%
- Test Efficacy Study on the Recommended Antimalarial Drugs in the Democratic Republic of the CongoCompletedPhase 4Ministry of Public Health, Democratic Republic of the CongoNCT06076213Written as Artesunate-amodiaquine
See all 115 studies that test Artesunate →
Given beside what is tested · 7 — Artesunate is usual care or a partner of the new treatment
- Rigorous Assessment of P. Vivax Relapses and Primaquine Efficacy for Radical CureCompletedPhase 4University of Maryland, BaltimoreNCT04706130Written as Artesunate
- A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)CompletedPhase 1Merck Sharp & Dohme LLCNCT06294912Written as Artesunate
- Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02996695Written as Artesunate
- Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina FasoCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02663700Written as Artesunate
- Evaluation of Oral Activated Charcoal on Antimalarial Drug's Ability to Kill Parasites in Malian Children With MalariaCompletedPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT01955382Written as Artesunate
- Chloroquine Alone or in Combination for Malaria in Children in MalawiCompletedPhase 3National Institute of Allergy and Infectious Diseases (NIAID)NCT00379821Written as Artesunate
- Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedPhase 2SanofiNCT00988507Written as artesunate
As the comparator · 11 — what is tested is compared with Artesunate
- To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum MalariaCompletedPhase 2Novartis PharmaceuticalsNCT04675931Written as IV Artesunate
- Effectiveness and Safety of Intermittent Preventive Treatment for Malaria Using Either Dihydroartemisinin-piperaquine or Artesunate-amodiaquine in Reducing Malaria Related Morbidities and Improving Cognitive Ability in School-aged Children in TanzaniaCompletedPhase 3National Institute for Medical Research, TanzaniaNCT03640403Written as Artesunate-amodiaquine
- Compare the Effectiveness Between Existing Treatment and New TreatmentTerminatedNot applicableUniversity of OxfordNCT01640587Written as Mefloquine+Artesunate
- Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria PatientsCompletedPhase 3Medicines for Malaria VentureNCT00403260Written as Mefloquine plus artesunate
- Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western CambodiaWithdrawnPhase 2/3University of OxfordNCT00936767Written as Artesunate
- Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in GhanaCompletedPhase 3Kwame Nkrumah University of Science and TechnologyNCT01231113Written as artesunate-amodiaquine
- Study on the Treatment of Vivax MalariaCompletedPhase 3University of OxfordNCT01074905Written as Artesunate
- Evaluation of Potential Effect of Artemether - Lumefantrine and Malaria Drugs on Auditory FunctionCompletedPhase 4NovartisNCT00444106Written as Artesunate-mefloquine
- Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in PeruCompletedPhase 3Institute of Tropical Medicine, BelgiumNCT00373607Written as Mefloquine + Artesunate
- Randomized Trial on Effectiveness of ACTs in GhanaTerminatedPhase 4Bernhard Nocht Institute for Tropical MedicineNCT00374205Written as Artesunate plus Amodiaquine
- Randomized Trial of Two Antimalarial Treatments for Clearing Low Density P.Falciparum Parasitaemia in SudanCompletedPhase 3London School of Hygiene and Tropical MedicineNCT00330902Written as sulfadoxine-pyrimethamine (SP) plus artesunate (AS)
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- AIM2-NLRP3 Inflammasome Dual Inhibitor on hsCRPNov 12, 2026NCT07933757
Codes
What other systems call Artesunate · ClinicalTrials.gg INT006699
- MeSH (NLM) D000077332ArtesunateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 60W3249T9MARTESUNATEConfirmed FDA, NLM, Wikidata
- RxNorm 18346Confirmed FDA, Wikidata
- Wikidata Q707939artesunateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C73005ArtesunateOne source FDA
- DrugBank DB09274One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077332 | Artesunate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 60W3249T9M | ARTESUNATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 18346 | — | Confirmed FDA, Wikidata |
| Wikidata | Q707939 | artesunate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C73005 | Artesunate | One source FDA |
| DrugBank | DB09274 | — | One source Wikidata |
Also registered as sodium artesunate (UNII CN5E49Z611).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.